| Price | 0.17p on 15-07-2026 at 18:35:13 |
|---|---|
| Change | 0.025p 17.24% |
| Buy | 0.18p |
| Sell | 0.16p |
| Last Trade: | Buy 561.00 at 0.178p |
| Day's Volume: | 52,401,401 |
| Last Close: | 0.17p |
| Open: | 0.145p |
| ISIN: | GB00BLH13C52 |
| Day's Range | 0.145p - 0.17p |
| 52wk Range: | 0.135p - 0.78p |
| Market Capitalisation: | £2.24m |
| VWAP: | 0.163339p |
| Shares in Issue: | 1.32b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
ValiRx (VAL) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 561 | 0.178p | Ordinary |
16:28:53 - 15-Jul-26 |
| Sell* | 1,500,000 | 0.162p | Ordinary |
16:22:35 - 15-Jul-26 |
| Sell* | 1,263,607 | 0.1625p | Ordinary |
16:22:29 - 15-Jul-26 |
| Sell* | 1,000,000 | 0.1625p | Ordinary |
16:22:20 - 15-Jul-26 |
| Buy* | 1,000,000 | 0.1744p | Ordinary |
16:16:02 - 15-Jul-26 |
| Buy* | 170,922 | 0.175p | Ordinary |
16:15:27 - 15-Jul-26 |
| Buy* | 339,943 | 0.1765p | Ordinary |
16:14:06 - 15-Jul-26 |
| Buy* | 24,322 | 0.177p | Ordinary |
16:13:51 - 15-Jul-26 |
| Unknown* | 10,000,000 | 0.17p | Negotiated Trade |
16:13:02 - 15-Jul-26 |
| Buy* | 500,000 | 0.17p | Ordinary |
16:12:43 - 15-Jul-26 |
ValiRx (VAL) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 22nd Jun 2026 7:00 am | RNS | Conclusion of Evaluation with University of Dundee |
| 22nd Jun 2026 7:00 am | RNS | Final Results & Notice of AGM |
| 2nd Jun 2026 7:00 am | RNS | Conclusion of Evaluation with Stingray |
| 1st Jun 2026 7:00 am | RNS | ValiRx Exercises Option on Evaluation Asset |
| 27th May 2026 7:00 am | RNS | Cytolytix Patent Granted |
| 21st May 2026 7:00 am | RNS | Result of Oversubscribed WRAP Retail Offer |
| 18th May 2026 7:00 am | RNS | WRAP Retail Offer for up to £150,000 |
| 15th May 2026 7:00 am | RNS | Fundraising of up to £1,155,000 |
| 31st Mar 2026 10:15 am | RNS | Change of Registered Office |
| 26th Mar 2026 7:00 am | RNS | ValiRx Commercial Update Q1 2026 |